MicroPort
US$29.009 Million (2019 Annual)[1] | |
Number of employees | 9000 (2022) |
---|---|
Website | www |
MicroPort is a
History
MicroPort was founded in 1998 by Zhaohua Chang, who currently serves as CEO, chairman, and Director.
Beginning in the 2010s, MicroPort has rapidly expanded around the world via international acquisitions to other medical device industries, including orthopedics and cardiac rhythm management.
In 2022, MicroPort established its US headquarters in Irvine, California with facilities that include a manufacturing base and innovation center.
Acquisitions
In 2014, MicroPort expanded operations in the United States by acquiring Wright Medical's OrthoRecon business to become the 6th largest international producer of orthopedic devices at the time.[21] MicroPort's orthopedic business is based in Arlington, Tennessee and in 2018 has expanded its business into India.[22]
In 2018, MicroPort and LivaNova closed the sale of LivaNova's cardiac rhythm management business for $190M.[17]
In 2018, MicroPort purchased Lombard Medical, a UK-based endovascular device company, from bankruptcy after it defaulted on loans in early 2018.[23]
In 2021, MicroPort purchased Hemovent GmbH, a German-based manufacturer of extracorporeal life support systems.[24]
References
- ^ a b c "MicroPort Annual Report 2019" (PDF). MicroPort.
- ^ "About Us". MicroPort. Archived from the original on 2019-05-11. Retrieved 2019-01-31.
- ^ "100 largest medtech companies". Becker's Healthcare. 8 September 2022.
- ^ "Medtech's top R&D spenders and the projects they launched". Medtech Design and Outsourcing. 28 February 2023.
- ^ "Zhaohua Chang Ph.D". MicroPort.
- ^ "Company Overview of Shanghai MicroPort Medical (Group) Co., Ltd". Bloomberg.
- ^ "Solution seeker: medical device developer provides international standards at lower price for Chinese patients". South China Morning Post. 10 September 2016.
- ^ "Global Cardiac Catheters Market Share 2018 Microport, Terumo, Cook and Lepu". Publicist Report.
- S2CID 52169067.
- S2CID 7244124.
- PMID 23506573.
- ^ "Round Table Expert - Firehawk Stent, proven fast healing from TARGET clinical program". EuroPCR.
- PMID 28894604.
- ^ Wendling, Patrice. "Boston Scientific Halts Bioabsorbable-Scaffold Program". Medscape. WebMD.
- ^ Fornell, Dave (8 September 2017). "Abbott Will End Sales of Absorb Bioresorbable Stent". Diagnostic and Interventional Cardiology. Scranton Gillette Communications.
- ^ "Surprising MicroPort Orthopedics". Orthopedics This Week.
- ^ a b "LivaNova closes $190 CRM sale to MicroPort". Mass Device. 30 April 2018.
- ^ "French leader promotes foreign investment at Versailles". Washington Post. Archived from the original on 2019-01-24.
- ^ "Real estate news: Chinese medical device maker plants U.S. HQ in Irvine". Orange County Register. 7 January 2022.
- ^ Kemp, Audrey (17 January 2022). "MicroPort Adds to Irvine Ops With New Exec Hire". Orange County Business Journal.
- ^ "MicroPort Scientific establishes MicroPort Orthopedics through the acquisition of Wright Medical's OrthoRecon business". Cision PR Newswire (Press release).
- ^ "MicroPort forays into orthopaedic implants". The Hans India. 24 February 2018.
- ^ "Lombard Medical Operations Acquired by MicroPort Scientific Corporation in a Restructuring Transaction". PR Newswire Association (Press release).
- ^ "ECLS Company Hemovent has been Acquired by MicroPort and Receives Investments in Expansion of German Operations". Business Wire (Press release). 4 October 2021.